Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,466Revenue (TTM) $M2,333Net Margin (%)-10.7Altman Z-Score0.8
Enterprise Value $M7,493EPS (TTM) $-3.1Operating Margin %-3.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-9.9Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %-8.2Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow132y-y EBITDA Growth Rate %-41.8ROA % (ttm)-4.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-14.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M87.6ROIC % (ttm)-3.5Gross Margin Increase y-yY

Gurus Latest Trades with ALR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ALR is held by these investors:



ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Guerdan MelissaSVP, Global Quality & Reg. 2016-02-01Sell2,500$54-5.57view
Hargadon Robert BernardSVP, Global Human Resources 2015-11-13Buy1,000$38.9930.78view
Hinrichs James F.Executive VP, CFO 2015-11-12Buy10,000$39.9727.57view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-03Sell5,135$52-1.94view
Gladwell MarkSenior VP, Global Operations 2015-09-03Sell2,651$52.27-2.45view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-01Sell5,000$50.481.01view
Gladwell MarkSenior VP, Global Operations 2015-08-31Sell27,513$52.23-2.37view
Malkani SanjayGlobal Pres., Toxicology 2015-08-14Sell31,460$54.6-6.61view
Hinrichs James F.Executive VP, CFO 2015-08-07Buy20,000$49.333.37view
Malkani SanjayGlobal Pres., Toxicology 2015-06-08Sell24,331$50.870.24view

Press Releases about ALR :

Quarterly/Annual Reports about ALR:

News about ALR:

Articles On GuruFocus.com
Watsa Buys 19 Holdings in What He Calls ‘Stock-Picker’s Market’ Nov 14 2017 
Lifshitz & Miller LLP Announces Investigation of Alere Inc., Emergent BioSolutions, Inc., Frontier C Oct 03 2017 
Alere Receives FDA Clearance for Alere™ i Influenza A & B 2 Rapid Molecular Test Oct 02 2017 
Alere Announces the U.S. Department of Justice Closes Investigation Sep 29 2017 
Abbott Acquisition of Alere Set to Close on October 3, 2017 Sep 29 2017 
Alere Reaches Settlement With SEC Sep 29 2017 
Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice Sep 28 2017 
Alere Announces Settlement with SEC Sep 28 2017 
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock Sep 18 2017 
Alere Announces Intent to Voluntarily Delist Series B Convertible Perpetual Preferred Stock from the Sep 18 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK